Smartleaf Asset Management »

Kymera Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $615 23 26.78

More positions owned by Smartleaf Asset Management

Vanguard World Mega Cap Val Etf (MGV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Mortgage Plus Bd (MTGP)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Wisdomtree Tr Us Quality Grow (QGRW)
Amazon (AMZN)

View all positions for Smartleaf Asset Management

Top funds holding Kymera Therapeutics

T. Rowe Price Associates
Baker Bros. Advisors
Atlas Venture Life Science Advisors
BVF
Wellington Management Company
Vanguard Group
FMR
venBio Select Advisor
BlackRock
Artal Group
Redmile Group
Rock Springs Capital Management
Geode Capital Management
Marshall Wace
Morgan Stanley

View all funds holding Kymera Therapeutics